Showing results (51-60 of 117) with videos related to
Sort By:
Pageof 12
Transplantation and Cellular Therapy|January 14, 2026
Population pharmacokinetics and optimal exposure of anti-thymocyte globulin in myeloablative hematopoietic cell transplantationHamid Ghazal, Sofia Leuchter, Riley Ngo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioningFrédéric Baron, Barry Storer, Michael B Maris, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2011
Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantationAbraham Guerrero, Stanley R Riddell, Jan Storek, et al.Archives of Neurology|June 19, 2010
Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantationJian-Qiang Lu, Jeffrey T Joseph, Richard A Nash, et al.International Journal of Molecular Sciences|December 23, 2022
Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host DiseaseGaurav Tripathi, Rutvij A Khanolkar, Rehan M Faridi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2012
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbiditiesAndrew Daly, Mary L Savoie, Michelle Geddes, et al.Journal of Autoimmunity|September 24, 2023
The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosisLamia Khan, Tahlia Derksen, Desiree Redmond, et al.Clinical Transplantation|May 24, 2022
Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplantAlex Chi Fung Kwan, Nikki Blosser, Sunita Ghosh, et al.Clinical Transplantation|November 9, 2017
Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantationAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 15, 2014
High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host diseaseSumit Chawla, Poonam Dharmani-Khan, Yiping Liu, et al.Pageof 12